2022 ICD-10-PCS Procedure Code XW023X7

Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7

    2022 - New Code Billable/Specific Code
  • ICD-10-PCS XW023X7 is a specific/billable code that can be used to indicate a procedure.
  • ICD-10-PCS XW023X7 is a new 2022 ICD-10-PCS code that became effective on October 1, 2021.
Code History
  • 2022 (effective 10/1/2021): New code

Convert XW023X7 to ICD-9-CM